Advertisement
Research Article Free access | 10.1172/JCI112882
Find articles by Morimoto, C. in: JCI | PubMed | Google Scholar
Find articles by Steinberg, A. in: JCI | PubMed | Google Scholar
Find articles by Letvin, N. in: JCI | PubMed | Google Scholar
Find articles by Hagan, M. in: JCI | PubMed | Google Scholar
Find articles by Takeuchi, T. in: JCI | PubMed | Google Scholar
Find articles by Daley, J. in: JCI | PubMed | Google Scholar
Find articles by Levine, H. in: JCI | PubMed | Google Scholar
Find articles by Schlossman, S. in: JCI | PubMed | Google Scholar
Published March 1, 1987 - More info
The cell surface phenotype of peripheral blood lymphocytes (PBL) of systemic lupus erythematosus (SLE) patients was characterized with the anti-2H4 monoclonal antibody that defines the human suppressor inducer subset. The T4+2H4+ population of cells has been shown to be critical for the activation of T8+ suppressor cells. Patients with SLE has a markedly decreased percentage of T4+2H4+ cells (13 +/- 2%) in their PBL compared with normal controls (21 +/- 1%) (P less than 0.001). This reduction was greatest in patients with active SLE, especially those with renal disease. Serial analysis of patients with SLE and renal disease showed a correlation between percent positive circulating T4+2H4+ cells and disease activity. Moreover, there was a significant correlation between a low percentage of T4+2H4+ cells and decreased suppressor-inducer function in autologous mixed lymphocyte reaction-activated T4+ cells from SLE patients. Thus, a deficiency exists in SLE patients with active renal disease in the T4+2H4+ suppressor-inducer T cell subset.